Improving the hemocompatibility of heart valves

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Heart valve replacement with a prosthetic heart valve (PHV) remains the most effective treatment for valvular diseases such as aortic stenosis (AS) and mitral regurgitation (MR); where degeneration is the most common aetiology followed by rheumatic disease. These relatively simple mechanical devices have considerably prolonged the lives of patients impacted with morbidity and poor prognosis. This has largely been possible to advancements in material science and valve design which have enhanced the durability of PHVs. However, issues with haemocompatibility such as haemolysis, thrombosis and calcification still often arise which can lead to mechanical obstruction or leaflet tearing, sometimes with fatal consequences. The journey to improving the haemocompatibility of heart valves has been complex, often driven by failure to join the loop between mechanical design and physiological requirements. This chapter explores two critical haemocompatibility themes; blood-valve surface interaction and the impact of valve design on blood flow, from early designs to refinement.
LanguageEnglish
Title of host publicationHemocompatibility of Biomaterials for Clinical Applications
Subtitle of host publicationBlood-Biomaterials Interactions
EditorsChristopher Siedlecki
Place of PublicationDuxford, UK
Pages395-429
Number of pages35
DOIs
Publication statusPublished - 3 Nov 2017

Fingerprint

Blood
Heart valve prostheses
Materials science
Durability

Keywords

  • haemocompatibility
  • heart valve
  • pyrolytic carbon
  • prosthetic valve thrombosis
  • surface engineering
  • valve design

Cite this

Gourlay, T., & Rozeik, M. (2017). Improving the hemocompatibility of heart valves. In C. Siedlecki (Ed.), Hemocompatibility of Biomaterials for Clinical Applications: Blood-Biomaterials Interactions (pp. 395-429). Duxford, UK. https://doi.org/10.1016/B978-0-08-100497-5.00012-4
Gourlay, T. ; Rozeik, M. / Improving the hemocompatibility of heart valves. Hemocompatibility of Biomaterials for Clinical Applications: Blood-Biomaterials Interactions. editor / Christopher Siedlecki. Duxford, UK, 2017. pp. 395-429
@inbook{9364aa590c3940c4816f446f147ee322,
title = "Improving the hemocompatibility of heart valves",
abstract = "Heart valve replacement with a prosthetic heart valve (PHV) remains the most effective treatment for valvular diseases such as aortic stenosis (AS) and mitral regurgitation (MR); where degeneration is the most common aetiology followed by rheumatic disease. These relatively simple mechanical devices have considerably prolonged the lives of patients impacted with morbidity and poor prognosis. This has largely been possible to advancements in material science and valve design which have enhanced the durability of PHVs. However, issues with haemocompatibility such as haemolysis, thrombosis and calcification still often arise which can lead to mechanical obstruction or leaflet tearing, sometimes with fatal consequences. The journey to improving the haemocompatibility of heart valves has been complex, often driven by failure to join the loop between mechanical design and physiological requirements. This chapter explores two critical haemocompatibility themes; blood-valve surface interaction and the impact of valve design on blood flow, from early designs to refinement.",
keywords = "haemocompatibility, heart valve, pyrolytic carbon, prosthetic valve thrombosis, surface engineering, valve design",
author = "T. Gourlay and M. Rozeik",
year = "2017",
month = "11",
day = "3",
doi = "10.1016/B978-0-08-100497-5.00012-4",
language = "English",
isbn = "978-0-08-100497-5",
pages = "395--429",
editor = "Christopher Siedlecki",
booktitle = "Hemocompatibility of Biomaterials for Clinical Applications",

}

Gourlay, T & Rozeik, M 2017, Improving the hemocompatibility of heart valves. in C Siedlecki (ed.), Hemocompatibility of Biomaterials for Clinical Applications: Blood-Biomaterials Interactions. Duxford, UK, pp. 395-429. https://doi.org/10.1016/B978-0-08-100497-5.00012-4

Improving the hemocompatibility of heart valves. / Gourlay, T.; Rozeik, M.

Hemocompatibility of Biomaterials for Clinical Applications: Blood-Biomaterials Interactions. ed. / Christopher Siedlecki. Duxford, UK, 2017. p. 395-429.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Improving the hemocompatibility of heart valves

AU - Gourlay, T.

AU - Rozeik, M.

PY - 2017/11/3

Y1 - 2017/11/3

N2 - Heart valve replacement with a prosthetic heart valve (PHV) remains the most effective treatment for valvular diseases such as aortic stenosis (AS) and mitral regurgitation (MR); where degeneration is the most common aetiology followed by rheumatic disease. These relatively simple mechanical devices have considerably prolonged the lives of patients impacted with morbidity and poor prognosis. This has largely been possible to advancements in material science and valve design which have enhanced the durability of PHVs. However, issues with haemocompatibility such as haemolysis, thrombosis and calcification still often arise which can lead to mechanical obstruction or leaflet tearing, sometimes with fatal consequences. The journey to improving the haemocompatibility of heart valves has been complex, often driven by failure to join the loop between mechanical design and physiological requirements. This chapter explores two critical haemocompatibility themes; blood-valve surface interaction and the impact of valve design on blood flow, from early designs to refinement.

AB - Heart valve replacement with a prosthetic heart valve (PHV) remains the most effective treatment for valvular diseases such as aortic stenosis (AS) and mitral regurgitation (MR); where degeneration is the most common aetiology followed by rheumatic disease. These relatively simple mechanical devices have considerably prolonged the lives of patients impacted with morbidity and poor prognosis. This has largely been possible to advancements in material science and valve design which have enhanced the durability of PHVs. However, issues with haemocompatibility such as haemolysis, thrombosis and calcification still often arise which can lead to mechanical obstruction or leaflet tearing, sometimes with fatal consequences. The journey to improving the haemocompatibility of heart valves has been complex, often driven by failure to join the loop between mechanical design and physiological requirements. This chapter explores two critical haemocompatibility themes; blood-valve surface interaction and the impact of valve design on blood flow, from early designs to refinement.

KW - haemocompatibility

KW - heart valve

KW - pyrolytic carbon

KW - prosthetic valve thrombosis

KW - surface engineering

KW - valve design

U2 - 10.1016/B978-0-08-100497-5.00012-4

DO - 10.1016/B978-0-08-100497-5.00012-4

M3 - Chapter

SN - 978-0-08-100497-5

SP - 395

EP - 429

BT - Hemocompatibility of Biomaterials for Clinical Applications

A2 - Siedlecki, Christopher

CY - Duxford, UK

ER -

Gourlay T, Rozeik M. Improving the hemocompatibility of heart valves. In Siedlecki C, editor, Hemocompatibility of Biomaterials for Clinical Applications: Blood-Biomaterials Interactions. Duxford, UK. 2017. p. 395-429 https://doi.org/10.1016/B978-0-08-100497-5.00012-4